ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Aditxt Inc

Aditxt Inc (ADTX)

0.07
-0.0049
(-6.54%)
Closed February 17 4:00PM
0.0683
-0.0017
(-2.43%)
After Hours: 7:59PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.0683
Bid
0.0677
Ask
0.0683
Volume
107,125,440
0.068 Day's Range 0.0794
0.065 52 Week Range 203.60
Market Cap
Previous Close
0.0749
Open
0.068
Last Trade Time
Financial Volume
$ 7,651,006
VWAP
0.071421
Average Volume (3m)
30,422,209
Shares Outstanding
14,234,210
Dividend Yield
-
PE Ratio
-0.03
Earnings Per Share (EPS)
-2.3
Revenue
645k
Net Profit
-32.7M

About Aditxt Inc

Aditxt Inc is a life sciences company which focuses on prolong life and enhance life quality of transplanted patients. The firm develop products designed to induce tolerance to transplanted organs. The firm's immunosuppressive (anti-rejection) drugs has made possible life-saving organ transplantatio... Aditxt Inc is a life sciences company which focuses on prolong life and enhance life quality of transplanted patients. The firm develop products designed to induce tolerance to transplanted organs. The firm's immunosuppressive (anti-rejection) drugs has made possible life-saving organ transplantation procedures as these drugs prevent or delay organ rejection. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) which utilizes tolerogenic approach that utilizes the body's natural process of cell death, to deliver a modified antigen that signals the immune system to become tolerant to transplanted tissues. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Camden, Delaware, USA
Founded
-
Aditxt Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ADTX. The last closing price for Aditxt was $0.07. Over the last year, Aditxt shares have traded in a share price range of $ 0.065 to $ 203.60.

Aditxt currently has 14,234,210 shares outstanding. The market capitalization of Aditxt is $1.07 million. Aditxt has a price to earnings ratio (PE ratio) of -0.03.

ADTX Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0299-30.44806517310.09820.11420.0651404584010.09027603CS
4-0.0754-52.47042449550.14370.14450.065491722840.0951079CS
12-0.2537-78.78881987580.3220.42270.065304222090.12443112CS
26-44.7317-99.847544642944.846.80.065151325570.60061223CS
52-154.3317-99.9557642487154.4203.60.06582337426.08512261CS
156-655.9317-99.9895884146656455840.0654219454493.63523558CS
260-8447.9317-99.99919152468448455840.06535792131489.26763204CS

ADTX - Frequently Asked Questions (FAQ)

What is the current Aditxt share price?
The current share price of Aditxt is $ 0.0683
How many Aditxt shares are in issue?
Aditxt has 14,234,210 shares in issue
What is the market cap of Aditxt?
The market capitalisation of Aditxt is USD 1.07M
What is the 1 year trading range for Aditxt share price?
Aditxt has traded in the range of $ 0.065 to $ 203.60 during the past year
What is the PE ratio of Aditxt?
The price to earnings ratio of Aditxt is -0.03
What is the cash to sales ratio of Aditxt?
The cash to sales ratio of Aditxt is 1.55
What is the reporting currency for Aditxt?
Aditxt reports financial results in USD
What is the latest annual turnover for Aditxt?
The latest annual turnover of Aditxt is USD 645k
What is the latest annual profit for Aditxt?
The latest annual profit of Aditxt is USD -32.7M
What is the registered address of Aditxt?
The registered address for Aditxt is 2140 S DUPONT HWY, KENT, CAMDEN, DELAWARE, 19934
What is the Aditxt website address?
The website address for Aditxt is www.aditxt.com
Which industry sector does Aditxt operate in?
Aditxt operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
JTAIJet AI Inc
$ 6.02
(133.33%)
104.48M
SRMSRM Entertainment Inc
$ 0.6999
(95.50%)
254.39M
WRDWeRide Inc
$ 31.4877
(83.39%)
21.07M
INLFINLIF Limited
$ 16.27
(80.58%)
7.68M
MBRXMoleculin Biotech Inc
$ 2.1201
(66.94%)
136.66M
BLACBellevue Life Sciences Acquisition Corporation
$ 3.08
(-56.31%)
430.77k
BLACUBellevue Life Sciences Acquisition Corporation
$ 3.36
(-52.68%)
5.21k
CSAICloudastructure Inc
$ 19.0001
(-49.58%)
1.03M
NEXNNexxen International Ltd
$ 10.30
(-49.16%)
164.82k
BSLKBolt Projects Holdings Inc
$ 0.6626
(-46.13%)
13.4M
CNSPCNS Pharmaceuticals Inc
$ 0.1415
(31.26%)
489.28M
MGOLMGO Global Inc
$ 0.7176
(-15.08%)
417.31M
SRMSRM Entertainment Inc
$ 0.6999
(95.50%)
254.39M
INTCIntel Corporation
$ 23.60
(-2.20%)
230.26M
NVDANVIDIA Corporation
$ 138.85
(2.63%)
194.99M

ADTX Discussion

View Posts
HoldEm777 HoldEm777 3 days ago
That rhetoric doesn’t match your IQ. So your sarcasm is noted. GLTY
👍️0
HoldEm777 HoldEm777 3 days ago
The “alert” creates an artificial rise in price. It usually coincides with a cover. “Hey someone is buying xyz stock”. The pump creates and maintains volume to sell short this artificial move because the cover and the alert was the only reason it happened to begin with. Then it gets hammered short.
Unless you identify this process your bagged from the start. Very few times do they actually get squeezed. Very few times the post split catalyst creates a run worth the time invested. Of course there are exceptions. These exceptions are like rat poison (to quote Nick Saban) . Everyone wants that huge runner so they load that next alert… blah blah blah.
The key is finding these setups before the initial cover imo.
👍️0
HoldEm777 HoldEm777 3 days ago
I would not say for certain they get kickbacks without knowing for certain they do. But I have been really watching close after how BIVI got rugged after the pre-split pump and they all follow the same pattern. They all get a cover handed to them as well.
When you apply logic to that pattern things don’t add up. If you follow what I am saying.
👍️0
HoldEm777 HoldEm777 3 days ago
I can’t say for sure what the reason is… but let me ask this…. Why do these companies that have been shorted to nothing decide to dilute dead bottom? Then split…. Then introduce a catalyst… pump the price …. Just to repeat the process?
It seems the existence of some of these companies is based on the fact it trades public so the business it does is irrelevant in the sense it just a vehicle to have a hedge in a short scheme.

These bulls pumping tops are really bears imo.
jmho.
👍️0
getmoreshares getmoreshares 3 days ago
RS vote 2/28 https://ih.advfn.com/stock-market/NASDAQ/aditxt-ADTX/stock-news/95318245/form-def-14a-other-definitive-proxy-statements
👍️0
TRADER99 TRADER99 3 days ago
When is the R/S ?
👍️0
getmoreshares getmoreshares 3 days ago
many of the Nasdaq positions under a buck are having a RS. There are lots of them!!!! ALWAYS DD! here is a good link: https://dilutiontracker.com/app/reverse-split
👍️0
sodamnsane sodamnsane 3 days ago
Why do all the pumpers with the biggest followings pump these pos stocks? Do they get kick backs from the bod? 
👍️0
rbl100 rbl100 3 days ago
UPDATE _ I got the phuck out now ! Not waiting until Tuesday so the shorters can drive down the price even more before I am allowed to sell. So I took my $5.26 loss and am moving on. Good riddance !
👍️ 2
MKII MKII 3 days ago
Are there notes from the fireside chat today?
👍️0
rbl100 rbl100 3 days ago
Well that does it ! Come Tuesday I am selling all my 100 shares ! I will lose just over $5.00. I always lose when I sell so I am used to it. Should have never bought another pos. Oh well phuck me again. Been buying stocks for almost 20 years and always lose.
👍️0
getmoreshares getmoreshares 3 days ago
RS vote 2/28 https://ih.advfn.com/stock-market/NASDAQ/aditxt-ADTX/stock-news/95318245/form-def-14a-other-definitive-proxy-statements
👍 1
rbl100 rbl100 3 days ago
What R/S? That was last year. I don't see any more in the near future. Did I miss something?
👍️0
HoldEm777 HoldEm777 3 days ago
It’s a rigged game of deception. BIVI, NIVF are a few that are examples recently.
👍️0
HoldEm777 HoldEm777 3 days ago
Or… the company and cronies are working together on a short with a guaranteed cover at bottom. Then split… then do it again… then again.. etc.
👍️0
don estaban don estaban 3 days ago
Seems to me that so far the premarket has been having less dilution maybe we made it thru the storm or maybe not
👍️0
shoondale shoondale 4 days ago
Would you believe what he said, without verification, considering the timing?
👍️0
koolmc koolmc 4 days ago
if the upcoming chat contains any juicy bit will get a pop before it split on watch
👍️0
TheFinalCD TheFinalCD 4 days ago
Aditxt to Host "Firesale" Chat on Friday😆
https://www.businesswire.com/news/home/20250213581038/en/
👍️0
Monroe1 Monroe1 4 days ago
Can you copy and paste it. My browser won't open it. Thanks
👍️0
TheFinalCD TheFinalCD 4 days ago
https://x.com/THIS_TIME_X/status/1890059591867912301
👍️0
Monroe1 Monroe1 4 days ago
The SEC has changed their tune and is not approving many RS actions that are intended to prevent delisting.
I expect the company to be aware of these new requirements where the RS will cause them to fail other requirements. But, who knows?
https://securities-law-blog.com/2025/02/04/nyse-amends-listing-standards-related-to-reverse-splits-to-meet-minimum-price/
👍️0
Monroe1 Monroe1 4 days ago
The diluters are diluting prior to the RS then will use those profits to buy at a discount immediately after the RS and then ride it up due to the news that is coming per Fireside chat. The PPS will recover quickly.
👍️0
getmoreshares getmoreshares 4 days ago
RS vote 2/28 https://ih.advfn.com/stock-market/NASDAQ/aditxt-ADTX/stock-news/95318245/form-def-14a-other-definitive-proxy-statements
👍️0
TheFinalCD TheFinalCD 4 days ago
$ADTX .06's on upcoming fireside chat PR to discuss possible Merger?

https://x.com/THIS_TIME_X/status/1890043696143601950

https://www.prnewswire.com/news-releases/syra-health-continues-to-secure-healthcare-training-contracts-302375936.html
👍️0
don estaban don estaban 4 days ago
The dilution here is insane never ending
👍️0
shoondale shoondale 5 days ago
Isn't Albanna working with Wainwright? It's going to be interesting to see what shareholders do at the end of the month
👍️0
TheFinalCD TheFinalCD 5 days ago
its a slow drain

by Wainwright

its disgusting

hopefully they run out of shares to sell so it can have a nice run
👍️0
don estaban don estaban 5 days ago
This was about the same amount of Vol. We closed at yesterday around 181 mil.
👍️0
TheFinalCD TheFinalCD 5 days ago
https://x.com/THIS_TIME_X/status/1889834708030083078
👍️0
shoondale shoondale 7 days ago
Yeah, it's called a reverse split..."something crazyy coming here"
👍️0
ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 7 days ago
ADTX~~watch for .50++ tomorrow, crazyy breakout
👍 1
ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 7 days ago
ADTX~~3,000,000 shares buy @.10, something crazyy coming here
👍 1
ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 7 days ago
ADTX~~5,000,000 shares buy @.10 cents, CRAZYYY huge
👍️0
nwsun nwsun 2 weeks ago
Looking at a 5 year chart of this stock it looks like a bear etf.
👍️0
slicknick617 slicknick617 2 weeks ago
Thank you !
👍️ 1
shoondale shoondale 2 weeks ago
What do you think now, ChartTRACKER? Seen enough carnage to change your opinion?
👍️0
shoondale shoondale 2 weeks ago
Probably this Nick: https://www.streetinsider.com/SEC+Filings/Form+DEF+14A+Aditxt%2C+Inc.+For%3A+Feb+28/24253726.html
Evidently, you can still vote during the virtual meeting.[
We are pleased to invite you to attend the special meeting of stockholders (the “Special Meeting”) of Aditxt, Inc. (the “Company”), which will be held on February 28, 2025 at 12:00 PM ET.

The Special Meeting will be held in a virtual-only meeting format at www.virtualshareholdermeeting.com/ADTX2025SM.

In addition to voting by submitting your proxy prior to the Special Meeting, you also will be able to vote your shares electronically during the Special Meeting. Further details regarding the virtual meeting are included in the accompanying proxy statement. At the Special Meeting, the holders of our outstanding common stock will act on the following matters:

1. To approve, for the purpose of Nasdaq Marketplace Rule 5635(d), the issuance of shares of common stock underlying shares of Series A-1 Convertible Preferred Stock originally issued by the Company in December 2023 (the “Series A-1 Proposal”);

2. To approve, for the purpose of Nasdaq Marketplace Rule 5635(d), the issuance of shares of common stock underlying shares of Series C-1 Convertible Preferred Stock and common stock purchase warrants originally issued by the Company in May 2024 and August 2024 (the “Series C-1 Proposal”);

3. To approve, for the purpose of Nasdaq Marketplace Rule 5635(d), the issuance of shares of common stock underlying common stock purchase warrants originally issued by the Company in July 2024 (the “July Warrant Proposal”);

4. To grant discretionary authority to our board of directors to (i) amend our certificate of incorporation to combine outstanding shares of our common stock into a lesser number of outstanding shares, or a “reverse stock split,” at a specific ratio within a range of one-for-five (1:5) to a maximum of a one-for-two hundred fifty (1:250) split, with the exact ratio to be determined by our board of directors in its sole discretion; and (ii) effect the reverse stock split, if at all, within one year of the date the proposal is approved by stockholders (the “Reverse Stock Split Proposal”);

5. To authorize the adjournment of the Special Meeting if necessary or appropriate, including to solicit additional proxies in the event that there are not sufficient votes at the time of the Special Meeting or adjournment or postponement thereof to approve any of the foregoing proposals (the “Adjournment Proposal”); and

6. To transact such other matters as may properly come before the Special Meeting and any adjournment or postponement thereof.

Our board of directors has fixed January 21, 2025 as the record date (the “Record Date”) for the determination of stockholders entitled to notice of, and to vote at, the Special Meeting and at any adjournment or postponement of the meeting.
👍️0
slicknick617 slicknick617 2 weeks ago
What was this thing I got in the mail ADTX sent me that my wife threw away before I could read ? Proxy for something ?
👍️0
nwsun nwsun 3 weeks ago
You make sense. Others obviously rely on hopeful innocence. Wall St, where sociopaths are trained.
🎯 1 👍️ 1
shoondale shoondale 3 weeks ago
ChartTRACKER
Re: None
Monday, January 13, 2025 8:04:51 PM
Post# 552 of 605
$ADTX : Wow! Didn't expect it to come to fruition, at least NOT
to $0.14!
It looked so Steady at $0.78 & $0.38!

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175348149
I'm not as confident as you that this has staying power to maintain the NASDAQ qualifications with the reverse split. What expenses will be "needed"? I've seen something steady too for many months ChartTRACKER....
👍️0
ChartTRACKER ChartTRACKER 3 weeks ago
$ADTX: Lay off the Kool-aid buddy!
250:1 😂 ! [You go that wrong too! You post is showing as a F/S]!!

A Company needs to maintain > 500k Shs to be listed on NASDAQ after a R/S.
👍️0
shoondale shoondale 3 weeks ago
Again February 28 is the meeting. They will delay the finality of the agenda to a later date only if they are not satisfied they have the votes to enact the reverse split. But the meeting will still take place at noon on the 28th of February. So maybe some deals are being worked out in private to secure the votes for the reverse split. I'm speculating the range is pure window dressing and the final ratio is 1:250. https://www.streetinsider.com/SEC+Filings/Form+DEF+14A+Aditxt%2C+Inc.+For%3A+Feb+28/24253726.html
We are pleased to invite you to attend the special meeting of stockholders (the “Special Meeting”) of Aditxt, Inc. (the “Company”), which will be held on February 28, 2025 at 12:00 PM ET.

The Special Meeting will be held in a virtual-only meeting format at www.virtualshareholdermeeting.com/ADTX2025SM.

In addition to voting by submitting your proxy prior to the Special Meeting, you also will be able to vote your shares electronically during the Special Meeting. Further details regarding the virtual meeting are included in the accompanying proxy statement. At the Special Meeting, the holders of our outstanding common stock will act on the following matters:

1. To approve, for the purpose of Nasdaq Marketplace Rule 5635(d), the issuance of shares of common stock underlying shares of Series A-1 Convertible Preferred Stock originally issued by the Company in December 2023 (the “Series A-1 Proposal”);

2. To approve, for the purpose of Nasdaq Marketplace Rule 5635(d), the issuance of shares of common stock underlying shares of Series C-1 Convertible Preferred Stock and common stock purchase warrants originally issued by the Company in May 2024 and August 2024 (the “Series C-1 Proposal”);

3. To approve, for the purpose of Nasdaq Marketplace Rule 5635(d), the issuance of shares of common stock underlying common stock purchase warrants originally issued by the Company in July 2024 (the “July Warrant Proposal”);

4. To grant discretionary authority to our board of directors to (i) amend our certificate of incorporation to combine outstanding shares of our common stock into a lesser number of outstanding shares, or a “reverse stock split,” at a specific ratio within a range of one-for-five (1:5) to a maximum of a one-for-two hundred fifty (1:250) split, with the exact ratio to be determined by our board of directors in its sole discretion; and (ii) effect the reverse stock split, if at all, within one year of the date the proposal is approved by stockholders (the “Reverse Stock Split Proposal”);

5. To authorize the adjournment of the Special Meeting if necessary or appropriate, including to solicit additional proxies in the event that there are not sufficient votes at the time of the Special Meeting or adjournment or postponement thereof to approve any of the foregoing proposals (the “Adjournment Proposal”); and

6. To transact such other matters as may properly come before the Special Meeting and any adjournment or postponement thereof.

Our board of directors has fixed January 21, 2025 as the record date (the “Record Date”) for the determination of stockholders entitled to notice of, and to vote at, the Special Meeting and at any adjournment or postponement of the meeting.
👍️0
rbl100 rbl100 3 weeks ago
Maybe so the date is flexible ?
👍️0
shurtha2000 shurtha2000 3 weeks ago
News coming
👍️0
shoondale shoondale 3 weeks ago
Kim Vs Albanna
Case Summary
On 10/17/2017 a Property - Other Property Fraud case was filed by Kim against Albanna in the jurisdiction of Riverside County Superior Courts, Riverside Historic Courthouse located in Riverside, California.

Case Details
Case Number
********

Filing Date
10/17/2017

Case Status
Disposed - Other Disposed

Case Type
Property - Other Property Fraud

Court
Riverside County Superior Courts

Courthouse
Riverside Historic Courthouse

County, State
Riverside, California
https://unicourt.com/case/ca-riv-kim-vs-albanna-1447455
"Serious question. Is this a scam company? The Yahoo's on there say it is. Anyone know?"...Ask Yong Kim what he thinks.
https://www.sec.gov/Archives/edgar/data/1726711/000121390020022991/ea125789ex10-1_aditx.htm
EX-10.1 2 ea125789ex10-1_aditx.htm AMENDMENT AGREEMENT, DATED AUGUST 19, 2020
Exhibit 10.1



AMENDMENT

TO

SERIES A WARRANT AGENT AGREEMENT



This AMENDMENT TO SERIES A WARRANT AGENT AGREEMENT (this “Amendment”) is dated as of August 19, 2020, by and between Aditx Therapeutics, Inc., a Delaware corporation (the “Company”) and VStock Transfer, LLC (the “Warrant Agent”). Capitalized terms used herein but otherwise not defined shall have the meanings ascribed to them in the Warrant Agreement (as defined below).



WHEREAS, the Company and the Warrant Agent previously entered into that certain Series A Warrant Agent Agreement (the “Warrant Agreement”), dated as of June 29, 2020, pursuant to which the Company issued Series A Warrants to purchase from the Company one share of the Company’s common stock per Series A Warrant (the “Series A Warrants”), at an exercise price of $9.00 per whole share, pursuant to the terms set forth in the Warrant Agreement;



WHEREAS, pursuant to Section 7.12 of the Warrant Agreement, the Company and the Warrant Agent may amend the Warrant Agreement without the consent of any holder of Series A Warrants for the purpose of changing any provisions of the Warrant Agreement that the parties determine, in good faith, shall not adversely affect the interest of the Holders; and



WHEREAS, the Company and the Warrant Agent desire to amend the Warrant Agreement to decrease the Exercise Price of the Series A Warrants from $9.00 per whole share to $4.50 per whole share.



NOW THEREFORE, for good and valuable consideration, the sufficiency of which is hereby acknowledged, the Company and Warrant Agent each agree to as follows:



1. Amendment to Exercise Price. The Exercise Price defined in Section 3.1 of the Warrant Agreement as “$9.00 per whole share” is hereby replaced with “$4.50 per whole share”.

2. Entire Agreement. Except as specifically set forth in this Amendment, the Warrant Agreement shall remain unaltered and in full force and effect and the respective terms, conditions or covenants thereof are hereby in all respects ratified and confirmed. In the event of a conflict between the terms of the Warrant Agreement and this Amendment, the terms of this Amendment shall govern.

3. Counterparts. This Amendment may be executed in any number of original, facsimile or electronic counterparts and each of such counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.

4. Governing Law. This Amendment shall be governed by and construed in accordance with the laws of the State of New York.

[Signature Page Follows]

1




IN WITNESS WHEREOF, this Amendment to Series A Warrant Agent Agreement has been duly executed by the parties hereto as of the day and year first above written.



ADITX THERAPEUTICS, INC.


By: /s/ Amro Albanna
Name: Amro Albanna
Title: Chief Executive Officer


VSTOCK TRANSFER, LLC


By: /s/ Young D. Kim
Name: Young D. Kim
Title: Compliance Officer
👍️0
shoondale shoondale 3 weeks ago
True blue Dr. Drew and Albanna...https://www.facebook.com/varneyco/videos/amro-albanna-and-dr-drew-on-aditx-covid-testing-device/1595447620655957/ This keeps getting better and better. What next? Will Dr. Oz gets on board?
👍️0
shoondale shoondale 3 weeks ago
Sporty...Big meeting coming up for you buddy and your fellow shareholders...Any questions. comments, or concerns Sporty?:
https://www.streetinsider.com/SEC+Filings/Form+DEF+14A+Aditxt%2C+Inc.+For%3A+Feb+28/24253726.html
Is the reverse split solely to avoid delisting? one-for-two hundred fifty (1:250)? Can anyone say ouch (that has to make everyone's bottom sore)? Why a virtual meeting instead of a face-to-face meeting? What if massive dilution ensues?
We are pleased to invite you to attend the special meeting of stockholders (the “Special Meeting”) of Aditxt, Inc. (the “Company”), which will be held on February 28, 2025 at 12:00 PM ET.

The Special Meeting will be held in a virtual-only meeting format at www.virtualshareholdermeeting.com/ADTX2025SM.

In addition to voting by submitting your proxy prior to the Special Meeting, you also will be able to vote your shares electronically during the Special Meeting. Further details regarding the virtual meeting are included in the accompanying proxy statement. At the Special Meeting, the holders of our outstanding common stock will act on the following matters:

1. To approve, for the purpose of Nasdaq Marketplace Rule 5635(d), the issuance of shares of common stock underlying shares of Series A-1 Convertible Preferred Stock originally issued by the Company in December 2023 (the “Series A-1 Proposal”);

2. To approve, for the purpose of Nasdaq Marketplace Rule 5635(d), the issuance of shares of common stock underlying shares of Series C-1 Convertible Preferred Stock and common stock purchase warrants originally issued by the Company in May 2024 and August 2024 (the “Series C-1 Proposal”);

3. To approve, for the purpose of Nasdaq Marketplace Rule 5635(d), the issuance of shares of common stock underlying common stock purchase warrants originally issued by the Company in July 2024 (the “July Warrant Proposal”);

4. To grant discretionary authority to our board of directors to (i) amend our certificate of incorporation to combine outstanding shares of our common stock into a lesser number of outstanding shares, or a “reverse stock split,” at a specific ratio within a range of one-for-five (1:5) to a maximum of a one-for-two hundred fifty (1:250) split, with the exact ratio to be determined by our board of directors in its sole discretion; and (ii) effect the reverse stock split, if at all, within one year of the date the proposal is approved by stockholders (the “Reverse Stock Split Proposal”);

5. To authorize the adjournment of the Special Meeting if necessary or appropriate, including to solicit additional proxies in the event that there are not sufficient votes at the time of the Special Meeting or adjournment or postponement thereof to approve any of the foregoing proposals (the “Adjournment Proposal”); and

6. To transact such other matters as may properly come before the Special Meeting and any adjournment or postponement thereof.

Our board of directors has fixed January 21, 2025 as the record date (the “Record Date”) for the determination of stockholders entitled to notice of, and to vote at, the Special Meeting and at any adjournment or postponement of the meeting.
👍️0
shoondale shoondale 3 weeks ago
Anyone know what happened here? Any info?
https://fortune.com/2023/12/13/evofem-birth-control-phexxi-startup-sold-aditxt/
NewsAditxt Inc.
Significant News Only
01/13/25 Press Release
Aditxt's Board of Directors Unanimously Approve Positioning Pearsanta for IPO to Support Global Launch of its Early Cancer Detection Platform
12/12/24 Press Release
Aditxt's Subsidiary Adimune Successfully Completes Preclinical Efficacy and Safety Studies for Its Immune Modulation Therapeutic ADI Platform, Advancing Toward First-in-Human Clinical Trials
11/19/24 Press Release
Appili Therapeutics Announces Receipt of Final Court Order for Arrangement with Aditxt, Inc.
11/14/24 Press Release
Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2025
11/08/24 Press Release
Aditxt Provides Update on Equity Line of Credit, ATM Usage, and Outstanding Number of Shares
11/07/24 Press Release
Aditxt's Target Acquisition Appili Therapeutics Announces Results of Special Meeting of Shareholders
11/06/24 Press Release
Appili Therapeutics Announces Results of Special Meeting of Shareholders
11/06/24 Press Release
Aditxt Acquisition Target Evofem Biosciences Secures Investor Support Through Voting Agreements for Merger with Aditxt's Subsidiary Adifem
11/06/24 Press Release
Evofem Secures Investor Support for Proposed Merger through Voting Agreements
10/31/24 Press Release
Aditxt's Target Acquisition Appili Therapeutics Announces Alignment with FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submission
10/31/24 Press Release
Appili Therapeutics Announces Alignment with FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submission
https://www.wsj.com/market-data/quotes/ADTX/company-people/executive-profile/186877783
👍️0
shoondale shoondale 3 weeks ago
Lookie! Lookie!...This is one talented family serving ADTX...https://www.aditxt.com/about/leadership/
Amro Albanna
Co-founder and Chief Executive Officer
Founded eight startups to commercialize innovations in various industries including enterprise software, research incubation, GPS & wireless, nano sensors, consumer health and biotech. Led multiple M&A and going-public transactions as a founder, co-founder and/or senior executive.
Rowena Albanna
Chief Operating Officer
Has over 20 years of experience serving in senior leadership roles that require synergies between operational and technical proficiencies for both technology startups and public companies. Experienced across a wide variety of industries including biotechnology, insect control, nanotechnology, consumer electronics, financial, telecommunications, e-commerce, online marketing, medical, and defense.
With talent like this family onboard; one wonders why the stock price has fallen off the cliff? 8 startups? Hmmm. I wonder what happened to them all? This requires more investigation.
Profile
Amro Albanna is the founder of VeriTeQ Corp.
(founded in 2002), Timely Technology Corp (founded in 1997), QMotions, Inc. (founded in 2003), Nano Engineered Applications, Inc. (founded in 2010), Innovation Economy Corp.
(founded in 2010), and Aditxt, Inc. (founded in 2017).
He held the title of President at Timely Technology Corp.
He held the title of Chief Executive Officer & Director at QMotions, Inc., Nano Engineered Applications, Inc., and Innovation Economy Corp.
Currently, Mr. Albanna is a Director at Smart Oxygen Solutions, Inc., Smartriverside, and Pearsanta, Inc. He was also the Chief Executive Officer & Director at Olfactor Laboratories, Inc. from 2010 to 2017.
Mr. Albanna obtained his undergraduate degree from California State University-San Bernardino in 1991.
https://www.marketscreener.com/insider/AMRO-ALBANNA-A16YCC/
👍️0

Your Recent History

Delayed Upgrade Clock